Exact Mass: 512.106

Exact Mass Matches: 512.106

Found 17 metabolites which its exact mass value is equals to given mass value 512.106, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

I-Bop

7-{3-[3-hydroxy-4-(4-iodophenoxy)but-1-en-1-yl]-7-oxabicyclo[2.2.1]heptan-2-yl}hept-5-enoic acid

C23H29IO5 (512.106)


   

C29H20O9

C29H20O9 (512.1107)


   

(-)-hopeanol|hopeanol

(-)-hopeanol|hopeanol

C29H20O9 (512.1107)


   

I-Bop

[1S-[1α,2α(Z),3β(1E,3S*),4α]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid

C23H29IO5 (512.106)


   

BMS-777607

N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide

C25H19ClF2N4O4 (512.1063)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

3,3-diethyl-2,2-oxathiacarbocyanine iodide

3,3-diethyl-2,2-oxathiacarbocyanine iodide

C25H25IN2O2 (512.0961)


   

9,10-Anthracenedione,2,2-(1,3,4-oxadiazole-2,5-diyl)bis[1-amino-

9,10-Anthracenedione,2,2-(1,3,4-oxadiazole-2,5-diyl)bis[1-amino-

C30H16N4O5 (512.1121)


   

2-CHLORO-N-(2-(PYRIDIN-3-YLAMINO)PYRIMIDIN-5-YL)-5-(3-(TRIFLUOROMETHYL)BENZAMIDO)BENZAMIDE

2-CHLORO-N-(2-(PYRIDIN-3-YLAMINO)PYRIMIDIN-5-YL)-5-(3-(TRIFLUOROMETHYL)BENZAMIDO)BENZAMIDE

C24H16ClF3N6O2 (512.0975)


   

decamethonium iodide

decamethonium iodide

C16H38I2N2 (512.1124)


   

BIS(3-ISOPROPYL-4-METHOXYPHENYL)IODONIUM TETRAFLUOROBORATE

BIS(3-ISOPROPYL-4-METHOXYPHENYL)IODONIUM TETRAFLUOROBORATE

C20H26BF4IO2 (512.1007)


   

Vat Red 31

Vat Red 31

C30H16N4O5 (512.1121)


   

Trovafloxacin Mesylate

Trovafloxacin Mesylate

C21H19F3N4O6S (512.0977)


A methanesulfonate (mesylate) salt prepared from equimolar amounts of trovafloxacin and methanesulfonic acid. A broad-spectrum antibiotic that was withdrawn from the market due to risk of liver failure. D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

1,1,2,2-tetrakis(4-nitrophenyl)ethene

1,1,2,2-tetrakis(4-nitrophenyl)ethene

C26H16N4O8 (512.0968)


   

Uranium tricarbide

Uranium tricarbide

U2C3 (512.1016)


   

(E)-7-[3-[(E)-3-hydroxy-4-(4-iodophenoxy)but-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid

(E)-7-[3-[(E)-3-hydroxy-4-(4-iodophenoxy)but-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid

C23H29IO5 (512.106)


   

methyl (1's,9'r)-3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-4,8'-dioxospiro[cyclohexane-1,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecan]-2,2',4',5,6',10',12',14'-octaene-1'-carboxylate

methyl (1's,9'r)-3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-4,8'-dioxospiro[cyclohexane-1,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecan]-2,2',4',5,6',10',12',14'-octaene-1'-carboxylate

C29H20O9 (512.1107)


   

methyl 3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-4,8'-dioxospiro[cyclohexane-1,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecan]-2,2',4',5,6',10',12',14'-octaene-1'-carboxylate

methyl 3',5',11',13'-tetrahydroxy-9'-(4-hydroxyphenyl)-4,8'-dioxospiro[cyclohexane-1,16'-tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadecan]-2,2',4',5,6',10',12',14'-octaene-1'-carboxylate

C29H20O9 (512.1107)